AIMSS — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Aromatase inhibitor-associated musculoskeletal syndrome (AIMSS)
AIMSS occurs in up to 50% of women on aromatase inhibitors. It presents with joint pain, stiffness (especially in hands), and myalgia, typically appearing within weeks to months of starting therapy. It is caused by oestrogen depletion in joints and tendons. Management includes exercise, analgesics, and switching to an alternative AI or tamoxifen if intolerable. Normal inflammatory markers and negative autoantibodies distinguish it from inflammatory arthritis.
Reference: Cancer Council Australia – 2024 – Breast Cancer Guidelines; AMH – 2025 – Aromatase Inhibitors